Home/Filings/4/0001127602-24-007020
4//SEC Filing

Abraham Silji 4

Accession 0001127602-24-007020

CIK 0000105770other

Filed

Feb 26, 7:00 PM ET

Accepted

Feb 27, 11:37 AM ET

Size

8.1 KB

Accession

0001127602-24-007020

Insider Transaction Report

Form 4
Period: 2024-02-23
Abraham Silji
Chief Digital & Trans Officer
Transactions
  • Exercise/Conversion

    Common Stock

    2024-02-23$173.22/sh+7,012$1,214,61911,672.258 total
  • Exercise/Conversion

    Stock Options (Right to Buy)

    2024-02-237,0120 total
    Exercise: $173.22From: 2021-02-18Exp: 2030-02-18Stock Options (Right to Buy) (7,012 underlying)
  • Sale

    Common Stock

    2024-02-23$365.00/sh7,012$2,559,3804,660.258 total
Footnotes (1)
  • [F1]This award vests in four equal annual installments beginning on February 18, 2021.

Issuer

WEST PHARMACEUTICAL SERVICES INC

CIK 0000105770

Entity typeother

Related Parties

1
  • filerCIK 0001733001

Filing Metadata

Form type
4
Filed
Feb 26, 7:00 PM ET
Accepted
Feb 27, 11:37 AM ET
Size
8.1 KB